TTFields harness physics to disrupt mitosis in cancer cells1-3

In preclinical models, TTFields have been shown to disrupt mitosis in cancer cells by exerting electric forces on their polar components (eg, microtubule spindle formation during mitosis), disrupting their normal localization (place in cell membrane) and function, ultimately leading to cell death.1-3

Explore each phase of mitosis to see the impact of TTFields

In metaphase:

TTFields impair microtubule assembly in cancer cells, leading to aberrant mitotic spindle formation.2,4 MD video

Watch below to see how TTFields disrupt mitosis in cancer cells

See the enhanced effects of TTFields when used with chemotherapy

See preclinical data

See how TTFields also interferes with cancer cell migration

References: 1. Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015;10(5):1-20. doi:10.1371/journal.pone.0125269 2. Giladi M, Schneiderman RS, Voloshin T, et al. Mitotic spindle disruption by alternating electric fields leads to improper chromosome segregation and mitotic catastrophe in cancer cells. Sci Rep. 2015;5:1-16. doi:10.1038/srep18046 3. Voloshin T, Kaynan N, Davidi S, et al. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunol Immunother. 2020;69(7):1191-1204. doi:10.1007/s00262-020-02534-7 4. Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality. Am Soc Clin Oncol Educ Book. 2012:126-131. doi:10.14694/EdBook_AM.2012.32.122 5. Mun EJ, Babiker HM, Weinberg U, Kirson ED, Von Hoff DD. Tumor-treating fields: a fourth modality in cancer treatment. Clin Cancer Res. 2018;24(2):266-275. doi:10.1158/1078-0432.CCR-17-1117

Novocure Websites

This website is intended for people seeking information on Novocure’s worldwide business.

 

On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals.

 

Patient images reflect the health status of the patients at the time each photo or video was taken.




All rights reserved.

MyLink, MyNovocure, Novocure, and Optune Gio are trademarks of Novocure GmbH.

All other trademarks, registered or unregistered, are the property of their respective owners.

GLB-NOV-0039 v6.0 August 2024